Fresh Tracks Therapeutics, Inc. (FRTX)

Fresh Tracks Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	8.01	8.01	6.94	0.4	1.82	7.92
Revenue Growth (YoY)	15.31%	15.31%	1618.56%	-77.83%	-76.99%	388.10%
Cost of Revenue	2.55	0	14.04	28.23	11.22	20.21
Gross Profit	5.46	8.01	-7.1	-27.83	-9.39	-12.3
Selling, General & Admin	11.18	11.18	14.43	12.42	11.58	12.17
Research & Development	3.18	3.18	14.04	28.23	11.22	20.21
Other Operating Expenses	0.67	0.67	0.44	0.84	0	0
Operating Expenses	14.37	14.37	28.48	40.65	22.8	32.39
Operating Income	-6.36	-6.36	-21.53	-40.24	-20.98	-24.47
Interest Income	0.01	0	0.01	0.07	0.06	1.94
Interest Expense	0.01	0.01	0.01	0.07	0	2.1
Other Expense / Income	-1.15	-1.35	-0.43	-0.77	-	-0.75
Pretax Income	-5.89	-5.69	-21.1	-39.47	-20.91	-23.88
Income Tax	0.43	0.68	-0.44	0.05	-0.01	2.07
Net Income	-5.63	-5.69	-20.66	-39.52	-20.9	-25.95
Shares Outstanding (Basic)	6	6	3	2	1	0
Shares Outstanding (Diluted)	6	6	3	2	1	0
Shares Change	96.23%	110.56%	57.33%	227.63%	710.92%	-3.12%
EPS (Basic)	-1.40	-0.96	-7.36	-22.14	-38.37	-386.21
EPS (Diluted)	-1.40	-0.96	-7.36	-22.14	-38.37	-386.21
Free Cash Flow	-4.34	-4.34	-19.38	-36.18	-20.06	-35.99
Free Cash Flow Per Share	-0.73	-0.73	-6.90	-20.27	-36.82	-535.71
Gross Margin	68.21%	100.00%	-102.26%	-6887.87%	-515.59%	-155.32%
Operating Margin	-79.44%	-79.44%	-310.15%	-9961.39%	-1151.26%	-309.06%
Profit Margin	-70.35%	-71.12%	-297.58%	-9782.43%	-1147.26%	-327.71%
Free Cash Flow Margin	-54.25%	-54.25%	-279.16%	-8956.44%	-1100.82%	-454.57%
EBITDA	-5.78	-5.65	-21.09	-40.24	-20.98	-24.47
EBITDA Margin	-72.15%	-70.55%	-303.80%	-9961.39%	-1151.26%	-309.06%
Depreciation & Amortization	0.04	0.04	0.03	0.02	0.01	0.03
EBIT	-5.82	-5.69	-21.12	-40.27	-20.99	-24.5
EBIT Margin	-72.66%	-71.06%	-304.23%	-9966.83%	-1151.81%	-309.41%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.